> ## Content Index > Fetch the complete content index at: https://www.neurabc.com/llms.txt > Use this file to discover other available public pages before exploring further. # NeuraBC is Live: The English Home of 神经新境 - URL: https://www.neurabc.com/neurabc-is-live-the-english-home-of-shen-jing-xin-jing/ - Published: 2026-10-25T04:00:00.000Z - Updated: 2026-10-25T03:59:59.000Z - Author: zhangguanghua We're live. Today marks the launch of **NeuraBC**​ — the official English website of **神经新境**, a global self-media brand dedicated to brain-computer interface coverage. Across platforms, 神经新境 has built an audience of **over 1,000,000 readers worldwide**​ — researchers, clinicians, investors, engineers, and enthusiasts following the neurotechnology sector in real time. Until now, that coverage lived primarily in Chinese-language channels. Today, we open a dedicated English front. NeuraBC is where 神经新境's global readership comes for original English reporting on China's BCI industry — its approvals, clinical trials, funding, supply chain, and the companies driving it forward. --- ### What we cover Every story centers on the commercialization of brain-computer interfaces in China: - **News**​ — Daily briefs on regulatory moves, trial milestones, deals, and policy shifts - **Analysis**​ — Deep dives that translate Chinese-language developments for an international readership - **Company Files**​ — Profiles and trackers on the players building China's BCI ecosystem - **Data**​ — Searchable timelines, funding tables, and approval records We publish on a regular schedule, starting with daily updates and weekly long-form pieces. --- ### Our editorial principles NeuraBC is fully independent. Our editorial decisions are guided by one standard: **accuracy and usefulness to our readers.**​ We follow a strict editorial policy, which you can read in full at Editorial Policy. Sponsored content, when published, will always be clearly disclosed. Editorial integrity is the foundation of everything we do. --- ### Why now China's BCI sector has entered a new phase. With the world's first commercial invasive BCI approval granted in March 2026, the industry has moved from laboratory research to market reality. The developments happening in Chinese hospitals, regulatory agencies, and venture capital firms will shape the global neurotechnology landscape for years to come. 神经新境 has been covering this story from the beginning. With NeuraBC, we bring that same editorial rigor to an English-speaking audience — directly, professionally, and continuously. --- ### Join us The best way to follow our coverage is to **subscribe.**​ We'll send a short email when we publish something worth your time. No spam, no noise — just signal. 👉 **Subscribe here** You can also connect with us on [LinkedIn](https://www.linkedin.com/in/neurabc/?ref=neurabc.com) and [X](https://x.com/NeuraBC?ref=neurabc.com). **Get in touch:** - 📧 Email: lovinzhang@neurabc.com - 💬 WeChat: `lovinzhang` - Tips, story ideas, or corrections? Reach us anytime. --- *© 2026 NeuraBC (神经新境). All rights reserved.*